You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
GTO scans today's edition of Science.
Neil Saunders blogs about the free scientific typesetting software called LaTeX.
A blogger runs through what the Roche buyout of 454 means to the community.
An online biologists' user group celebrates its 20th birthday.
A philosopher suggests that lab classes are expendable.
GTO scans today's edition of Nature.
A feature story in Scientific American looks at the genetics behind alcoholism.
Scientists in the UK have a theory about why we're not all attractive. Um, thanks.
Claire Fraser-Liggett resigns from TIGR, but mum's the word on her future plans.
The 'father of MRI' dies at 77.
A new study indicates that Darwin's publishing delay wasn't related to concerns about the church.
Going through the tenure process is funny. Really.
NYT profiles researchers advancing the state of the art in lifelike robotics.
Can't get enough years in school? An executive asks the Wall Street Journal if he should get an MBA.
A New York Times article chronicles the past few decades of science students who killed their advisors.
The Gizmodo blog urges readers to kick in cycles for the [email protected] proteomics project.
A Taipei-based effort will set up a genetic database to help screen for promising athletes.
A Seoul scientist says he successfully cloned wolves.
A new bill wants to train science grad students in communication.
Treating deadly diseases is all fun and games till they start swapping genes with other organisms to resist therapy.
A consumer group released a report saying that FDA's plan to allow the sale of cloned livestock products was based on little data and too much biotech lobbying.
GTO wraps up this week's edition of Science.
A blogger reports on how personalized medicine has made headway in clinical trials for multiple myeloma.
A genetic nondiscrimination bill that's been floating around the US Congress for the past 12 years now looks like it may be passed.
GTO scans today's issue of Nature.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.